nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Lung infiltration—Carmustine—malignant glioma	0.0421	0.046	CcSEcCtD
Acebutolol—Dry eye—Temozolomide—malignant glioma	0.0176	0.0193	CcSEcCtD
Acebutolol—Abnormal vision—Carmustine—malignant glioma	0.0172	0.0188	CcSEcCtD
Acebutolol—Abnormal vision—Temozolomide—malignant glioma	0.0166	0.0182	CcSEcCtD
Acebutolol—Eye pain—Carmustine—malignant glioma	0.0159	0.0174	CcSEcCtD
Acebutolol—Eye pain—Temozolomide—malignant glioma	0.0153	0.0168	CcSEcCtD
Acebutolol—Amnesia—Carmustine—malignant glioma	0.0152	0.0167	CcSEcCtD
Acebutolol—Hot flush—Temozolomide—malignant glioma	0.0148	0.0162	CcSEcCtD
Acebutolol—Amnesia—Temozolomide—malignant glioma	0.0147	0.0161	CcSEcCtD
Acebutolol—Menopausal symptoms—Temozolomide—malignant glioma	0.0147	0.0161	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0147	0.0161	CcSEcCtD
Acebutolol—Affect lability—Temozolomide—malignant glioma	0.0136	0.0149	CcSEcCtD
Acebutolol—Mood swings—Temozolomide—malignant glioma	0.0131	0.0143	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0125	0.0136	CcSEcCtD
Acebutolol—Dysuria—Temozolomide—malignant glioma	0.0112	0.0122	CcSEcCtD
Acebutolol—Pneumonia—Carmustine—malignant glioma	0.0111	0.0121	CcSEcCtD
Acebutolol—Erectile dysfunction—Temozolomide—malignant glioma	0.011	0.0121	CcSEcCtD
Acebutolol—Depression—Carmustine—malignant glioma	0.011	0.012	CcSEcCtD
Acebutolol—Weight increased—Temozolomide—malignant glioma	0.0109	0.0119	CcSEcCtD
Acebutolol—Pneumonia—Temozolomide—malignant glioma	0.0107	0.0117	CcSEcCtD
Acebutolol—Depression—Temozolomide—malignant glioma	0.0106	0.0116	CcSEcCtD
Acebutolol—Hallucination—Carmustine—malignant glioma	0.00986	0.0108	CcSEcCtD
Acebutolol—Hypoaesthesia—Carmustine—malignant glioma	0.00986	0.0108	CcSEcCtD
Acebutolol—Connective tissue disorder—Carmustine—malignant glioma	0.00974	0.0107	CcSEcCtD
Acebutolol—Visual impairment—Carmustine—malignant glioma	0.00955	0.0104	CcSEcCtD
Acebutolol—Hypoaesthesia—Temozolomide—malignant glioma	0.00953	0.0104	CcSEcCtD
Acebutolol—Hallucination—Temozolomide—malignant glioma	0.00953	0.0104	CcSEcCtD
Acebutolol—Pharyngitis—Temozolomide—malignant glioma	0.0095	0.0104	CcSEcCtD
Acebutolol—Connective tissue disorder—Temozolomide—malignant glioma	0.00941	0.0103	CcSEcCtD
Acebutolol—Visual impairment—Temozolomide—malignant glioma	0.00923	0.0101	CcSEcCtD
Acebutolol—Flushing—Carmustine—malignant glioma	0.00919	0.0101	CcSEcCtD
Acebutolol—Tinnitus—Temozolomide—malignant glioma	0.00893	0.00977	CcSEcCtD
Acebutolol—Flushing—Temozolomide—malignant glioma	0.00889	0.00973	CcSEcCtD
Acebutolol—Alopecia—Carmustine—malignant glioma	0.00875	0.00958	CcSEcCtD
Acebutolol—Angiopathy—Temozolomide—malignant glioma	0.00869	0.00951	CcSEcCtD
Acebutolol—Mediastinal disorder—Temozolomide—malignant glioma	0.00863	0.00944	CcSEcCtD
Acebutolol—Chills—Temozolomide—malignant glioma	0.00859	0.0094	CcSEcCtD
Acebutolol—Alopecia—Temozolomide—malignant glioma	0.00846	0.00926	CcSEcCtD
Acebutolol—Back pain—Carmustine—malignant glioma	0.00834	0.00913	CcSEcCtD
Acebutolol—Vision blurred—Carmustine—malignant glioma	0.00813	0.0089	CcSEcCtD
Acebutolol—Back pain—Temozolomide—malignant glioma	0.00806	0.00882	CcSEcCtD
Acebutolol—Vision blurred—Temozolomide—malignant glioma	0.00785	0.0086	CcSEcCtD
Acebutolol—Ill-defined disorder—Temozolomide—malignant glioma	0.00773	0.00846	CcSEcCtD
Acebutolol—Malaise—Temozolomide—malignant glioma	0.00752	0.00823	CcSEcCtD
Acebutolol—Vertigo—Temozolomide—malignant glioma	0.00749	0.0082	CcSEcCtD
Acebutolol—Palpitations—Temozolomide—malignant glioma	0.00737	0.00806	CcSEcCtD
Acebutolol—Chest pain—Carmustine—malignant glioma	0.00734	0.00804	CcSEcCtD
Acebutolol—Myalgia—Carmustine—malignant glioma	0.00734	0.00804	CcSEcCtD
Acebutolol—Anxiety—Carmustine—malignant glioma	0.00732	0.00801	CcSEcCtD
Acebutolol—Cough—Temozolomide—malignant glioma	0.00727	0.00796	CcSEcCtD
Acebutolol—Confusional state—Carmustine—malignant glioma	0.0071	0.00777	CcSEcCtD
Acebutolol—Arthralgia—Temozolomide—malignant glioma	0.0071	0.00777	CcSEcCtD
Acebutolol—Myalgia—Temozolomide—malignant glioma	0.0071	0.00777	CcSEcCtD
Acebutolol—Anxiety—Temozolomide—malignant glioma	0.00707	0.00774	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00705	0.00771	CcSEcCtD
Acebutolol—Oedema—Carmustine—malignant glioma	0.00704	0.0077	CcSEcCtD
Acebutolol—Discomfort—Temozolomide—malignant glioma	0.00701	0.00767	CcSEcCtD
Acebutolol—Confusional state—Temozolomide—malignant glioma	0.00686	0.00751	CcSEcCtD
Acebutolol—Oedema—Temozolomide—malignant glioma	0.0068	0.00744	CcSEcCtD
Acebutolol—Anorexia—Carmustine—malignant glioma	0.00671	0.00734	CcSEcCtD
Acebutolol—Nervous system disorder—Temozolomide—malignant glioma	0.00667	0.0073	CcSEcCtD
Acebutolol—Skin disorder—Temozolomide—malignant glioma	0.00661	0.00723	CcSEcCtD
Acebutolol—Hypotension—Carmustine—malignant glioma	0.00658	0.0072	CcSEcCtD
Acebutolol—Hyperhidrosis—Temozolomide—malignant glioma	0.00658	0.0072	CcSEcCtD
Acebutolol—Anorexia—Temozolomide—malignant glioma	0.00648	0.0071	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00641	0.00702	CcSEcCtD
Acebutolol—Insomnia—Carmustine—malignant glioma	0.00637	0.00697	CcSEcCtD
Acebutolol—Paraesthesia—Carmustine—malignant glioma	0.00632	0.00692	CcSEcCtD
Acebutolol—Dyspnoea—Carmustine—malignant glioma	0.00628	0.00687	CcSEcCtD
Acebutolol—Somnolence—Carmustine—malignant glioma	0.00626	0.00685	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0062	0.00678	CcSEcCtD
Acebutolol—Insomnia—Temozolomide—malignant glioma	0.00615	0.00673	CcSEcCtD
Acebutolol—Decreased appetite—Carmustine—malignant glioma	0.00612	0.0067	CcSEcCtD
Acebutolol—Paraesthesia—Temozolomide—malignant glioma	0.00611	0.00669	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00608	0.00665	CcSEcCtD
Acebutolol—Dyspnoea—Temozolomide—malignant glioma	0.00606	0.00664	CcSEcCtD
Acebutolol—Somnolence—Temozolomide—malignant glioma	0.00605	0.00662	CcSEcCtD
Acebutolol—Pain—Carmustine—malignant glioma	0.00602	0.00659	CcSEcCtD
Acebutolol—Constipation—Carmustine—malignant glioma	0.00602	0.00659	CcSEcCtD
Acebutolol—Dyspepsia—Temozolomide—malignant glioma	0.00599	0.00655	CcSEcCtD
Acebutolol—Decreased appetite—Temozolomide—malignant glioma	0.00591	0.00647	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00587	0.00643	CcSEcCtD
Acebutolol—Fatigue—Temozolomide—malignant glioma	0.00586	0.00642	CcSEcCtD
Acebutolol—Constipation—Temozolomide—malignant glioma	0.00582	0.00637	CcSEcCtD
Acebutolol—Pain—Temozolomide—malignant glioma	0.00582	0.00637	CcSEcCtD
Acebutolol—Feeling abnormal—Carmustine—malignant glioma	0.0058	0.00635	CcSEcCtD
Acebutolol—Gastrointestinal pain—Carmustine—malignant glioma	0.00576	0.0063	CcSEcCtD
Acebutolol—Feeling abnormal—Temozolomide—malignant glioma	0.00561	0.00613	CcSEcCtD
Acebutolol—Body temperature increased—Carmustine—malignant glioma	0.00556	0.00609	CcSEcCtD
Acebutolol—Abdominal pain—Carmustine—malignant glioma	0.00556	0.00609	CcSEcCtD
Acebutolol—Gastrointestinal pain—Temozolomide—malignant glioma	0.00556	0.00609	CcSEcCtD
Acebutolol—Urticaria—Temozolomide—malignant glioma	0.0054	0.00591	CcSEcCtD
Acebutolol—Abdominal pain—Temozolomide—malignant glioma	0.00538	0.00589	CcSEcCtD
Acebutolol—Body temperature increased—Temozolomide—malignant glioma	0.00538	0.00589	CcSEcCtD
Acebutolol—Asthenia—Carmustine—malignant glioma	0.00505	0.00553	CcSEcCtD
Acebutolol—Asthenia—Temozolomide—malignant glioma	0.00488	0.00534	CcSEcCtD
Acebutolol—Diarrhoea—Carmustine—malignant glioma	0.00482	0.00527	CcSEcCtD
Acebutolol—Pruritus—Temozolomide—malignant glioma	0.00481	0.00527	CcSEcCtD
Acebutolol—Dizziness—Carmustine—malignant glioma	0.00465	0.00509	CcSEcCtD
Acebutolol—Diarrhoea—Temozolomide—malignant glioma	0.00465	0.00509	CcSEcCtD
Acebutolol—Dizziness—Temozolomide—malignant glioma	0.0045	0.00492	CcSEcCtD
Acebutolol—Vomiting—Carmustine—malignant glioma	0.00448	0.0049	CcSEcCtD
Acebutolol—Rash—Carmustine—malignant glioma	0.00444	0.00486	CcSEcCtD
Acebutolol—Dermatitis—Carmustine—malignant glioma	0.00443	0.00485	CcSEcCtD
Acebutolol—Headache—Carmustine—malignant glioma	0.00441	0.00483	CcSEcCtD
Acebutolol—Vomiting—Temozolomide—malignant glioma	0.00432	0.00473	CcSEcCtD
Acebutolol—Rash—Temozolomide—malignant glioma	0.00429	0.00469	CcSEcCtD
Acebutolol—Dermatitis—Temozolomide—malignant glioma	0.00428	0.00469	CcSEcCtD
Acebutolol—Headache—Temozolomide—malignant glioma	0.00426	0.00466	CcSEcCtD
Acebutolol—Nausea—Carmustine—malignant glioma	0.00418	0.00458	CcSEcCtD
Acebutolol—Nausea—Temozolomide—malignant glioma	0.00404	0.00442	CcSEcCtD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	8.92e-05	0.00103	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ASMT—malignant glioma	8.91e-05	0.00103	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	8.91e-05	0.00103	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	8.89e-05	0.00103	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HEY1—malignant glioma	8.85e-05	0.00103	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR4—malignant glioma	8.85e-05	0.00103	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPHK1—malignant glioma	8.84e-05	0.00102	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	8.79e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR4—malignant glioma	8.66e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HEY1—malignant glioma	8.66e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIST1H3B—malignant glioma	8.6e-05	0.000997	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	8.6e-05	0.000996	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIST1H3B—malignant glioma	8.41e-05	0.000975	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ASMT—malignant glioma	8.4e-05	0.000973	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—BCAN—malignant glioma	8.38e-05	0.000971	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCL8—malignant glioma	8.23e-05	0.000953	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MMP3—malignant glioma	8.21e-05	0.000951	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.18e-05	0.000948	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCL8—malignant glioma	8.05e-05	0.000932	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MMP3—malignant glioma	8.03e-05	0.000931	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	7.98e-05	0.000925	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BCAN—malignant glioma	7.89e-05	0.000915	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAG2—malignant glioma	7.85e-05	0.00091	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.79e-05	0.000902	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAG2—malignant glioma	7.68e-05	0.00089	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTT1—malignant glioma	7.6e-05	0.00088	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	7.5e-05	0.000869	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS1—malignant glioma	7.12e-05	0.000825	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	6.77e-05	0.000785	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—IDH2—malignant glioma	6.75e-05	0.000782	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—H3F3A—malignant glioma	6.64e-05	0.00077	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—BCHE—malignant glioma	6.62e-05	0.000767	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—F2—malignant glioma	6.6e-05	0.000764	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCR3—malignant glioma	6.58e-05	0.000762	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SLC5A5—malignant glioma	6.54e-05	0.000757	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—H3F3A—malignant glioma	6.5e-05	0.000753	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—F2—malignant glioma	6.45e-05	0.000748	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCR3—malignant glioma	6.44e-05	0.000746	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NTRK2—malignant glioma	6.4e-05	0.000742	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—YWHAE—malignant glioma	6.4e-05	0.000742	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FLT1—malignant glioma	6.37e-05	0.000738	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—IDH2—malignant glioma	6.36e-05	0.000737	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2B6—malignant glioma	6.35e-05	0.000736	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DUSP6—malignant glioma	6.35e-05	0.000735	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CG—malignant glioma	6.31e-05	0.000731	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAG1—malignant glioma	6.26e-05	0.000726	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NTRK2—malignant glioma	6.26e-05	0.000725	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—YWHAE—malignant glioma	6.26e-05	0.000725	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH3—malignant glioma	6.24e-05	0.000723	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FLT1—malignant glioma	6.23e-05	0.000722	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.23e-05	0.000722	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DUSP6—malignant glioma	6.21e-05	0.000719	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	6.18e-05	0.000716	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FBXW7—malignant glioma	6.14e-05	0.000711	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAG1—malignant glioma	6.13e-05	0.00071	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	6.1e-05	0.000707	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.09e-05	0.000706	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.02e-05	0.000697	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	6.02e-05	0.000697	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FBXW7—malignant glioma	6e-05	0.000696	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—F2—malignant glioma	5.99e-05	0.000694	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2B6—malignant glioma	5.98e-05	0.000693	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	5.89e-05	0.000682	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—F2—malignant glioma	5.86e-05	0.000679	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—IDH1—malignant glioma	5.81e-05	0.000673	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.8e-05	0.000672	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	5.78e-05	0.000669	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.76e-05	0.000667	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	5.73e-05	0.000664	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	5.65e-05	0.000655	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	5.63e-05	0.000653	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SPHK1—malignant glioma	5.62e-05	0.000651	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	5.61e-05	0.00065	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	5.6e-05	0.000648	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	5.55e-05	0.000643	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	5.51e-05	0.000638	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2C18—malignant glioma	5.51e-05	0.000638	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KNG1—malignant glioma	5.48e-05	0.000634	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	5.47e-05	0.000634	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—IDH1—malignant glioma	5.47e-05	0.000634	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	5.43e-05	0.000629	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KNG1—malignant glioma	5.36e-05	0.000621	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SPHK1—malignant glioma	5.3e-05	0.000613	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.29e-05	0.000613	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTP1—malignant glioma	5.27e-05	0.00061	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	5.25e-05	0.000608	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	5.22e-05	0.000605	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2C18—malignant glioma	5.19e-05	0.000601	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	5.13e-05	0.000595	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAT—malignant glioma	5.12e-05	0.000594	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.12e-05	0.000593	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	5.11e-05	0.000591	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	5.04e-05	0.000584	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	4.93e-05	0.000571	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP3—malignant glioma	4.85e-05	0.000562	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NCOR1—malignant glioma	4.84e-05	0.000561	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	4.84e-05	0.00056	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	4.81e-05	0.000557	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP3—malignant glioma	4.75e-05	0.00055	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	4.73e-05	0.000548	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	4.7e-05	0.000545	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTK2—malignant glioma	4.67e-05	0.000541	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	4.65e-05	0.000539	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HES1—malignant glioma	4.59e-05	0.000531	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTK2—malignant glioma	4.57e-05	0.000529	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	4.56e-05	0.000528	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	4.55e-05	0.000527	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	4.5e-05	0.000521	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HES1—malignant glioma	4.49e-05	0.00052	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	4.46e-05	0.000517	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTT1—malignant glioma	4.45e-05	0.000516	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	4.44e-05	0.000515	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	4.4e-05	0.00051	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	4.39e-05	0.000509	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	4.37e-05	0.000506	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	4.35e-05	0.000504	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.32e-05	0.000501	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	4.3e-05	0.000498	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	4.27e-05	0.000495	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SPP1—malignant glioma	4.24e-05	0.000491	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	4.22e-05	0.000489	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTT1—malignant glioma	4.2e-05	0.000486	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS1—malignant glioma	4.17e-05	0.000483	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPP1—malignant glioma	4.15e-05	0.000481	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	4.13e-05	0.000478	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—malignant glioma	4.03e-05	0.000467	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—malignant glioma	4.02e-05	0.000466	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—malignant glioma	3.95e-05	0.000457	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAV1—malignant glioma	3.94e-05	0.000457	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—malignant glioma	3.93e-05	0.000456	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS1—malignant glioma	3.93e-05	0.000455	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	3.92e-05	0.000455	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	3.9e-05	0.000452	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—BCHE—malignant glioma	3.88e-05	0.000449	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	3.84e-05	0.000445	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	3.84e-05	0.000445	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC5A5—malignant glioma	3.83e-05	0.000444	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	3.82e-05	0.000442	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	3.76e-05	0.000436	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CAV1—malignant glioma	3.72e-05	0.000431	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—malignant glioma	3.68e-05	0.000426	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BCHE—malignant glioma	3.65e-05	0.000423	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CAV1—malignant glioma	3.64e-05	0.000421	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.61e-05	0.000418	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—malignant glioma	3.6e-05	0.000417	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—malignant glioma	3.59e-05	0.000416	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FN1—malignant glioma	3.54e-05	0.00041	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—F2—malignant glioma	3.54e-05	0.00041	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.53e-05	0.000409	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BAD—malignant glioma	3.5e-05	0.000405	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARG—malignant glioma	3.47e-05	0.000402	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	3.46e-05	0.000401	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FN1—malignant glioma	3.46e-05	0.000401	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—F2—malignant glioma	3.46e-05	0.000401	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BAD—malignant glioma	3.42e-05	0.000396	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD80—malignant glioma	3.39e-05	0.000393	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	3.39e-05	0.000393	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APC—malignant glioma	3.39e-05	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	3.39e-05	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGF—malignant glioma	3.35e-05	0.000388	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	3.33e-05	0.000386	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD80—malignant glioma	3.32e-05	0.000385	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APC—malignant glioma	3.31e-05	0.000384	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	3.31e-05	0.000384	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGF—malignant glioma	3.28e-05	0.000379	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	3.26e-05	0.000377	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BRAF—malignant glioma	3.18e-05	0.000369	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—malignant glioma	3.16e-05	0.000366	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BRAF—malignant glioma	3.11e-05	0.000361	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT2—malignant glioma	3.1e-05	0.000359	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTP1—malignant glioma	3.09e-05	0.000358	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	3.09e-05	0.000357	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT2—malignant glioma	3.03e-05	0.000351	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	3.02e-05	0.00035	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAT—malignant glioma	3e-05	0.000348	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	2.98e-05	0.000345	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	2.95e-05	0.000342	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	2.92e-05	0.000338	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	2.91e-05	0.000337	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTP1—malignant glioma	2.91e-05	0.000337	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	2.89e-05	0.000334	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	2.85e-05	0.00033	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF2—malignant glioma	2.85e-05	0.00033	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOR1—malignant glioma	2.84e-05	0.000329	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAT—malignant glioma	2.83e-05	0.000328	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF2—malignant glioma	2.79e-05	0.000323	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—malignant glioma	2.75e-05	0.000319	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—malignant glioma	2.73e-05	0.000316	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	2.68e-05	0.00031	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOR1—malignant glioma	2.67e-05	0.00031	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MDM2—malignant glioma	2.67e-05	0.000309	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAF1—malignant glioma	2.66e-05	0.000308	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	2.63e-05	0.000305	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	2.62e-05	0.000304	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MDM2—malignant glioma	2.61e-05	0.000302	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAF1—malignant glioma	2.6e-05	0.000301	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	2.6e-05	0.000301	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	2.57e-05	0.000298	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	2.54e-05	0.000294	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	2.49e-05	0.000289	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	2.44e-05	0.000283	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	2.41e-05	0.000279	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—malignant glioma	2.39e-05	0.000277	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—malignant glioma	2.38e-05	0.000276	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—malignant glioma	2.38e-05	0.000276	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	2.36e-05	0.000273	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—malignant glioma	2.34e-05	0.000271	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—malignant glioma	2.33e-05	0.00027	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAV1—malignant glioma	2.31e-05	0.000268	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—malignant glioma	2.26e-05	0.000261	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—malignant glioma	2.24e-05	0.00026	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—malignant glioma	2.21e-05	0.000256	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—malignant glioma	2.19e-05	0.000254	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	2.19e-05	0.000253	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAV1—malignant glioma	2.18e-05	0.000252	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	2.14e-05	0.000248	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—malignant glioma	2.11e-05	0.000244	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARG—malignant glioma	2.03e-05	0.000235	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	2.03e-05	0.000235	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—malignant glioma	2.01e-05	0.000232	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.98e-05	0.00023	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	1.98e-05	0.00023	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—malignant glioma	1.96e-05	0.000227	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARG—malignant glioma	1.92e-05	0.000222	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—malignant glioma	1.86e-05	0.000216	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—malignant glioma	1.85e-05	0.000214	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—malignant glioma	1.82e-05	0.000211	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—malignant glioma	1.82e-05	0.000211	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—malignant glioma	1.78e-05	0.000207	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.74e-05	0.000202	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—malignant glioma	1.72e-05	0.0002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—malignant glioma	1.68e-05	0.000195	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.68e-05	0.000194	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—malignant glioma	1.61e-05	0.000187	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—malignant glioma	1.6e-05	0.000185	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	1.58e-05	0.000183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	1.55e-05	0.000179	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—malignant glioma	1.53e-05	0.000177	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.52e-05	0.000176	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—malignant glioma	1.51e-05	0.000175	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—malignant glioma	1.5e-05	0.000173	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—malignant glioma	1.39e-05	0.000162	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—malignant glioma	1.37e-05	0.000159	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—malignant glioma	1.31e-05	0.000152	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—malignant glioma	1.29e-05	0.00015	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—malignant glioma	1.26e-05	0.000146	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—malignant glioma	9.84e-06	0.000114	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—malignant glioma	9.27e-06	0.000107	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—malignant glioma	8.04e-06	9.31e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—malignant glioma	7.57e-06	8.77e-05	CbGpPWpGaD
